SBN 0.00% 0.0¢ sun biomedical limited

new opportunities?, page-11

  1. 3,662 Posts.
    lightbulb Created with Sketch. 542
    looks like a pretty big wall of sellers from here until 2c which would need some volume to knock down.

    C'mon directors make some on-market purchases!

    I also found that the SBN director Anton Uvarov is an analyst for RM Research, who have recently put out research reports on CDY and PAA plus a few miners (like SEG).

    here's the one for PAA as an example:

    http://www.rmresearch.com.au/wp-content/uploads/RM-Research-PharmAust-Limited-11-November-2013.pdf

    I would expect one for SBN sometime soon but probably when things are more advanced.
 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.